Winning the Exclusivity Game in Europe
In the fiercely competitive landscape of pharmaceutical innovation, securing market exclusivity isn’t just a strategic advantage—it’s often the difference between success and obsolescence. Yet, as the recent insights from DrugPatentWatch reveal, naviga…
